EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

  1. Álvarez-Vázquez, A.
  2. San-Segundo, L.
  3. Cerveró-García, P.
  4. Flores-Hernández, R.
  5. Ollauri-Ibáñez, C.
  6. Segura-Collar, B.
  7. Hubert, C.G.
  8. Morrison, G.
  9. Pollard, S.M.
  10. Lathia, J.D.
  11. Sánchez-Gómez, P.
  12. Tabernero, A.
Aldizkaria:
Neuro-Oncology

ISSN: 1523-5866,  1522-8517

Argitalpen urtea: 2024

Alea: 26

Zenbakia: 7

Orrialdeak: 1230-1246

Mota: Artikulua

DOI: 10.1093/NEUONC/NOAE060 GOOGLE SCHOLAR lock_openSarbide irekia editor